E 150 E 150 (Nizatidine 150 mg)
Pill imprint E 150 E 150 has been identified as Nizatidine 150 mg.
Nizatidine is used in the treatment of gerd; indigestion; erosive esophagitis; duodenal ulcer prophylaxis; duodenal ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
- E 150 E 150
- 150 mg
- Yellow & White
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- corn starch
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
|21695-0375||Rebel Distributors Corp (repackager)|
|54569-5924||A-S Medication Solutions, LLC (repackager)|
|16590-0741||Stat RX USA LLC (repackager)|
More about nizatidine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 6 Reviews – Add your own review/rating
- Drug class: H2 antagonists
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.